Atlas Trials

Serum Galectin-3 as a Marker of Human Papillomavirus Infection

Clinical trial NCT06005389 · COMPLETED

Trial details

NCT number
NCT06005389
Sponsor
Assiut University
Status
COMPLETED
Study type
OBSERVATIONAL
Human Papillomavirus Infection
Start date
2021-12-01
Primary completion
2022-12-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.